GPD1 Antikörper

Produktnummer ABIN631716

Produktdetails anti-GPD1 Antikörper

Target: GPD1 (Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) (GPD1))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser GPD1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Affinity purified

Immunogen: GPD1 antibody was raised using a synthetic peptide corresponding to a region with amino acids TFLESCGVADLITTCYGGRNRKVAEAFARTGKSIEQLEKELLNGQKLQGP

Anwendungsinformationen

Applikationshinweise: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

GPD1 Blocking Peptide, catalog no. 33R-9068, is also available for use as a blocking control in assays to test for specificity of this GPD1 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GPD1 antibody in PBS

Konzentration: Lot specific

Buffer: PBS

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Details zu GPD1

Target: GPD1 (Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) (GPD1))

Andere Bezeichnung: GPD1 (GPD1 Produkte)

Synonyme: GPDH antikoerper, Gpd3 antikoerper, GPD-C antikoerper, GPDH-C antikoerper, HTGTI antikoerper, CG9042 antikoerper, DROGPDHA antikoerper, DmG3PDH antikoerper, Dmel\\CG9042 antikoerper, G3PDH antikoerper, G3pdh antikoerper, GAPDH antikoerper, GPD antikoerper, GPDA antikoerper, GPDH-1 antikoerper, Gdh antikoerper, Gpd antikoerper, alpha-GPD antikoerper, alpha-GPDH antikoerper, alpha-GPDH-1 antikoerper, alpha-Gpdh antikoerper, alphaGPDH antikoerper, alphaGpd antikoerper, alphaGpdh antikoerper, alphaGpdh-1 antikoerper, gpdh antikoerper, gpdh-1 antikoerper, sn-Gpdh antikoerper, AI747587 antikoerper, Gdc-1 antikoerper, Gdc1 antikoerper, mKIAA4010 antikoerper, gpd1 antikoerper, wu:fc30a07 antikoerper, zgc:63859 antikoerper, MGC79676 antikoerper, GPD1 antikoerper, LG3P antikoerper, zgc:112197 antikoerper, Gpd1 antikoerper, gpd1h antikoerper, gpd1l antikoerper, wu:fc58b05 antikoerper, zgc:66051 antikoerper, zgc:85742 antikoerper, glycerol-3-phosphate dehydrogenase 1 antikoerper, Glycerol-3-phosphate dehydrogenase [NAD(+)] antikoerper, glycerol-3-phosphate dehydrogenase antikoerper, Glycerol 3 phosphate dehydrogenase antikoerper, glycerol-3-phosphate dehydrogenase 1 (soluble) antikoerper, glycerol-3-phosphate dehydrogenase 1 L homeolog antikoerper, glycerol-3-phosphate dehydrogenase 1c antikoerper, glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic antikoerper, glycerol-3-phosphate dehydrogenase 1a antikoerper, glycerol-3-phosphate dehydrogenase 1b antikoerper, Gpd1 antikoerper, gpdh-1 antikoerper, GPD1 antikoerper, Tb11.02.5280 antikoerper, Gpdh antikoerper, gpd1.L antikoerper, gpd1c antikoerper, gpd1 antikoerper, LOC101071719 antikoerper, gpd1a antikoerper, gpd1b antikoerper

Hintergrund: GPD1L belongs to the NAD-dependent glycerol-3-phosphate dehydrogenase family. Defects in GPD1L are the cause of Brugada syndrome type 2 (BRS2) and sudden infant death syndrome (SIDS).

Molekulargewicht: 37 kDa (MW of target protein)